BiotechTube

Ertapenem + Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin + Metronidazole + Amoxicillin-Clavulanate + Sulopenem

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Intra Abdominal Infections

Conditions

Intra Abdominal Infections

Trial Timeline

Sep 18, 2018 → Oct 2, 2019

NCT ID
NCT03358576

About Ertapenem + Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin + Metronidazole + Amoxicillin-Clavulanate + Sulopenem

Ertapenem + Sulopenem-Etzadroxil/Probenecid + Ciprofloxacin + Metronidazole + Amoxicillin-Clavulanate + Sulopenem is a phase 3 stage product being developed by Iterum Therapeutics for Intra Abdominal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT03358576. Target conditions include Intra Abdominal Infections.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT03358576Phase 3Completed

Competing Products

20 competing products in Intra Abdominal Infections

See all competitors
ProductCompanyStageHype Score
Tirzepatide + Tirzepatide PlaceboEli LillyApproved
85
pudexacianinium chlorideAstellas PharmaPhase 3
77
pudexacianinium chlorideAstellas PharmaPhase 3
77
Mirabegron + PlaceboAstellas PharmaPhase 1
33
Edaravone Dexborneol + PlaceboSun PharmaceuticalPhase 2
52
KW-3357Kyowa KirinPhase 3
77
KW-3357Kyowa KirinPhase 3
77
KW-3357 + Plasma-derived antithrombinKyowa KirinPhase 3
77
PemetrexedEli LillyPhase 2
52
Budesonide NasalJohnson & JohnsonApproved
85
ApatinibJiangsu Hengrui MedicinePhase 2
52
Apatinib and Adebrelimab in Combination With chemotherapyJiangsu Hengrui MedicinePhase 2
52
ApatinibJiangsu Hengrui MedicinePhase 2
52
FamitinibJiangsu Hengrui MedicinePhase 2
52
Camrelizumab + ApatinibJiangsu Hengrui MedicinePhase 2
52
Durvalumab + SNDX-6352AstraZenecaPhase 2
52
Ticagrelor + Aspirin + Rivaroxaban + Aspirin + Clopidogrel + AspirinAstraZenecaPhase 3
77
Durvalumab + TremelimumabAstraZenecaPhase 2
52
Pemigatinib + DurvalumabAstraZenecaPhase 2
52
AZD4017 + Placebo + AZD4017 + PlaceboAstraZenecaPhase 2
52

Other Products from Iterum Therapeutics

CiprofloxacinApproved
77
Sulopenem etzadroxil/probenecid + Amoxicillin/clavulanatePhase 3
69
Sulopenem-Etzadroxil/Probenecid + CiprofloxacinPhase 3
69
Sulopenem + Sulopenem-Etzadroxil/Probenecid + Ertapenem + Ciprofloxacin + Amoxicillin-clavulanatePhase 3
69
Azithromycin plus hydroxychloroquinePhase 3
69